RecruitingNot ApplicableNCT04063592

AMI Construction in Lower Extremity Residual Limbs

A Novel Approach to Lower Extremity Residual Limb Revision to Augment Volitional Motor Control, Restore Proprioception and Reverse Limb Atrophy


Sponsor

Brigham and Women's Hospital

Enrollment

26 participants

Start Date

Feb 24, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This study will involve the development of a novel approach to lower extremity residual limb surgical revision that offers the promise of augmenting volitional motor control, restore proprioception and reverse atrophy


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Residual limb revision for people with amputation. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREResidual limb revision

Surgical procedure involving construction of agonist-antagonist myoneural interfaces (AMIs)


Locations(3)

Walter Reed National Military Medical Center

Bethesda, Maryland, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

Massachusetts Institute of Technology

Cambridge, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04063592


Related Trials